ADVBAdvanced Biomed Inc. Common Stock

NAS · US · Healthcare · Diagnostics & Research · advanbiomed.com

8.140USDMkt Cap: 13.45M $P/E: 2.043d ago

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include …

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

$13.92BUSDP/E 59.7

ICLR

ICON Public Limited Company

Twist Bioscience Corp.

$9.13BUSD

Key Statistics

Company

Market Cap13.45M $

Enterprise Value9.35M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)4.76M $

Revenue/Share—

Last Price8.140 USD

Fiscal Year EndJun 2025

MR QuarterMar 2026

Employees31

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)2.04

P/E (Forward)—

PEG—

EV/EBITDA-3.18

EV/Revenue—

P/S—

P/B1.22

EPS (TTM)4.00

EPS (Forward)—

52W Range

7.200100% of range8.140

52W High8.140 USD

52W Low7.200 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE71.33%

ROA-21.50%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.13M $

CapEx (TTM)74.11K $

FCF Margin—

FCF Yield-63.12%

Net Debt-1.90M $

Net Debt/EBITDA0.65

Balance Sheet

Debt/Equity7.74

Current Ratio7.38

Quick Ratio1.90

Book Value/Sh6.663 USD

Cash/Share1.890 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:20

Split DateFeb 20, 2026

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.1.65M

Float777.16K

Insiders73.91%

Institutions0.00%

Short Interest

Short Ratio0.0d

Short % Float6.57%

Short % Out.3.46%

Shares Short57.21K

Short (prev mo.)15.40K

Technical

SMA 507.206 (+13.0%)

SMA 2006.215 (+31.0%)

Beta—

S&P 52W Chg19.18%

Avg Vol (30d)79.43K

Avg Vol (10d)267.72K

Technical Indicators

RSI (14)49.7

MACD0.1119

MACD Signal0.2661

MACD Hist.-0.1542

BB Upper12.18 USD

BB Middle8.704 USD

BB Lower5.229 USD

BB Width79.84%

ATR (14)1.716 USD

Vol Ratio (20d)0.18x